Comprehensive panels take out the guess work, giving laboratories and healthcare providers a higher probability of identifying pathogens associated with infectious disease.

The FDA De Novo authorized BioFire RP2.1 Panel is a frontline test to help clinicians quickly diagnose respiratory infections, including COVID-19.

Two minutes of hands-on time and one small sample to operate with the BioFire® FilmArray® panels helps clinics diagnose patients in about an hour.

Detection of respiratory pathogens just got faster and more comprehensive with the BioFire FilmArray Respiratory Panels.

The BioFire Customer Support team has compiled answers to some of the most frequently asked questions about the FilmArray to assist you.

The BioFire BCID Panel tests for a comprehensive set of 24 gram positive, gram negative and yeast pathogens and 3 antibiotic resistance genes associated with bloodstream infections.

BioFire® Respiratory Panel 2.1 (RP2.1) Testing - BioFire Diagnostics

The CLIA-waived BioFire RP EZ panel uses a syndromic approach to fast, easy, and comprehensive results to help treat your patients faster.

Here are some simple steps to help maintain your BioFire FilmArray System, prevent problems from arising, and ensure accurate results.

BioFire is committed to training and educating our customers through training videos and webinars. Stay informed by watching our videos.